metricas
covid
Buscar en
Gastroenterología y Hepatología (English Edition)
Toda la web
Inicio Gastroenterología y Hepatología (English Edition) Implementing telemedicine in inflammatory bowel disease: Is COVID-19 the definit...
Journal Information

Statistics

Follow this link to access the full text of the article

Editorial
Implementing telemedicine in inflammatory bowel disease: Is COVID-19 the definitive trigger?
Implementación de la telemedicina en la enfermedad inflamatoria intestinal: ¿es la COVID-19 el impulso definitivo?
Javier Del Hoyoa, Mariam Aguasa,b,c,
Corresponding author
m.aguas.peris@gmail.com

Corresponding author.
a Unidad de Enfermedad Inflamatoria Intestinal, Servicio de Medicina Digestiva, Hospital Universitari i Politècnic La Fe, Valencia, Spain
b Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
c Instituto de Investigación Sanitaria La Fe, Valencia, Spain
Read
380
Times
was read the article
57
Total PDF
323
Total HTML
Share statistics
Article information
ISSN: 24443824
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 July 8 1 9
2024 June 8 4 12
2024 May 12 3 15
2024 April 14 3 17
2024 March 14 4 18
2024 February 9 2 11
2024 January 11 3 14
2023 December 9 4 13
2023 November 12 2 14
2023 October 13 1 14
2023 September 15 2 17
2023 August 15 2 17
2023 July 6 1 7
2023 June 16 4 20
2023 May 36 1 37
2023 April 27 2 29
2023 March 12 0 12
2023 February 10 3 13
2023 January 7 5 12
2022 December 11 2 13
2022 November 11 4 15
2022 October 11 4 15
2022 September 13 0 13
2022 August 5 0 5
2022 July 3 0 3
2022 June 2 0 2
2022 May 2 0 2
2022 April 4 0 4
2022 March 3 0 3
2022 February 2 0 2
2022 January 1 0 1
2021 February 1 0 1
Show all

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos